Pfizer Invites Proposals for Psoriatic Arthritis Educational Projects
Through its Global Medical Grants program, Pfizer supports independent initiatives (e.g., research, quality improvement, education) focused on improving patient outcomes in areas of unmet medical need that are aligned with the company’s medical and/or scientific strategies.
To that end, Pfizer is accepting proposals for educational programs aimed at HCPs, including rheumatologists, dermatologists, and primary care practitioners, nurse practitioners, and physician assistants, who treat psoriatic arthritis.
Through the program, grants of up to $250,000 will be awarded in support of educational projects focused on improving the overall care and diagnosis of patients with PsA by increasing healthcare provider knowledge and management of the disease state, including an understanding of comorbidities as well as unmet needs in the treatment of PsA. Programs should also highlight how advances in treatment goals and measures can be used to monitor disease activity, as well as education around the latest guidelines.
Eligible applicants include medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. If the project involves multiple departments within an institution and/or between different institutions /organizations/associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
See the Pfizer website for complete program guidelines and application instructions.